Wilk, Aaron J. http://orcid.org/0000-0003-1430-5852
Rustagi, Arjun http://orcid.org/0000-0002-6921-1012
Zhao, Nancy Q. http://orcid.org/0000-0001-6217-854X
Roque, Jonasel
Martínez-Colón, Giovanny J.
McKechnie, Julia L.
Ivison, Geoffrey T. http://orcid.org/0000-0002-3612-0069
Ranganath, Thanmayi http://orcid.org/0000-0001-9865-2119
Vergara, Rosemary
Hollis, Taylor
Simpson, Laura J.
Grant, Philip
Subramanian, Aruna
Rogers, Angela J. http://orcid.org/0000-0001-6969-6200
Blish, Catherine A. http://orcid.org/0000-0001-6946-7627
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DP1 DA04608902)
Burroughs Wellcome Fund (1016687)
U.S. Department of Health & Human Services | National Institutes of Health (T32 GM007365-44, T32 AI007502-23, AI007290-35, AI007290-35)
Agency for Science, Technology and Research
National Science Foundation (DGE-1656518)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K23 HL125663)
Article History
Received: 17 April 2020
Accepted: 19 May 2020
First Online: 8 June 2020
Competing interests
: The authors declare no competing interests.
Free to read: This content has been made available to all.